ADNI is associated with several organizations. See the related groups below:
This website offers additional information for investigators about the ADNI study, data collection, the ADNI grant and acquiring data and samples.
The Alzheimer’s Disease Cooperative Study (ADCS) is a major initiative for Alzheimer’s disease clinical studies in the federal government, addressing treatments for both cognitive and behavioral symptoms. ADCS is part of the NIA Division of Neuroscience’s effort to facilitate the discovery, development and testing of new drugs for Alzheimer’s disease.
The Australian Imaging, Biomarkers & Lifestyle Flagship Study of Ageing (AIBL) is a study of over 1,100 people assessed to determine which biomarkers, cognitive characteristics, and health and lifestyle factors determine subsequent development of symptomatic Alzheimer’s disease.
The Alzheimer Research Forum reports on the latest scientific findings, from basic research to clinical trials and creates and maintains public databases of essential research data and reagents. The forum promotes debate and speeds the dissemination of new ideas while breaking down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer’s disease.
The Alzheimer’s Association is the leading, global voluntary health organization in Alzheimer’s care and support, and the largest private, nonprofit funder of Alzheimer’s research.
|E-ADNI (European ADNI)
The aim of this pilot project is to demonstrate that the core ADNI methodology, i.e. standardized and centralized collection of MR imaging, clinical data, blood, and CSF samples can be adopted by European Centers of the European Alzheimer’s Disease Consortium (EADC).
|J-ADNI (Japanese ADNI)
Japanese clinicians and researchers started Japanese ADNI (J-ADNI), which is sponsored by governmental funding bodies (NEDO and MHLW) as well as pharmas, in April 2007.